Access

Letters to Nature

Nature 431, 471-476 (23 September 2004) | doi:10.1038/nature02844; Received 25 May 2004; Accepted 14 July 2004

Exogenous control of mammalian gene expression through modulation of RNA self-cleavage

Laising Yen1, Jennifer Svendsen1, Jeng-Shin Lee1, John T. Gray1, Maxime Magnier1, Takashi Baba2, Robert J. D'Amato2 & Richard C. Mulligan1

  1. Department of Genetics, Harvard Institute of Human Genetics, Harvard Medical School, and Division of Molecular Medicine, Children's Hospital, Boston, Massachusetts 02115, USA
  2. Department of Surgery, Children's Hospital, Boston, Massachusetts 02115, USA

Correspondence to: Richard C. Mulligan1 Email: mulligan@receptor.med.harvard.edu

Top

Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences1, 2, 3, 4. Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs5 into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies6, this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Boolean calculations made easy (for ribozymes)

Nature Biotechnology News and Views (01 Nov 2005)

The end defines the means in bacterial mRNA decay

Nature Chemical Biology News and Views (01 Sep 2007)

See all 6 matches for News And Views